{"groups":[{"description":"Patients with a deleterious BRCA (breast cancer susceptibility gene) mutation detected in their tumor.","id":"FG000","title":"BRCA Mutation"},{"description":"Patients with a deleterious ATM (ataxia telangiectasia mutated serine/threonine kinase) mutation detected in their tumor.","id":"FG001","title":"ATM Mutation"},{"description":"Patients with a deleterious CDK12 (Cyclin-dependent kinase 12) mutation detected in their tumor.","id":"FG002","title":"CDK12 Mutation"},{"description":"Patients with a deleterious CHEK2 (Checkpoint Kinase 2) mutation detected in their tumor.","id":"FG003","title":"CHEK2 Mutation"},{"description":"Patients with other deleterious HRR (homologous recombination repair) gene mutation detected in their tumor.","id":"FG004","title":"Other Gene Mutation"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"172"},{"groupId":"FG001","numSubjects":"59"},{"groupId":"FG002","numSubjects":"14"},{"groupId":"FG003","numSubjects":"7"},{"groupId":"FG004","numSubjects":"25"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"172"},{"groupId":"FG001","numSubjects":"59"},{"groupId":"FG002","numSubjects":"14"},{"groupId":"FG003","numSubjects":"7"},{"groupId":"FG004","numSubjects":"25"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}],"recruitmentDetails":"A total of 277 patients were recruited from 102 sites across 12 countries."}